SMS Pharmaceuticals’ manufacturing facility-Unit II located at Bachupally, Ranga Reddy District, Hyderabad, Telangana, India was successfully inspected by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities. The inspection was carried out between July 25, 2017 to July 27, 2017.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.